Frequency of all types of MBL and of CLL-like MBL in different age groups
| Age group, y . | All individuals . | All MBL (%) . | CLL-like MBL (%) . | Non–CLL-like MBL (%)* . |
|---|---|---|---|---|
| <40 | 403 | 7 (1.7) | 1 (0.2) | 6 (1.5) |
| 40-49 | 235 | 6 (2.5) | 4 (1.7) | 2 (0.9) |
| 50-59 | 317 | 19 (6.0) | 15 (4.7) | 4 (1.3) |
| 60-69 | 355 | 37 (10.4) | 31 (8.7) | 6 (1.7) |
| 70-79 | 264 | 34 (12.9) | 24 (9.1) | 10 (3.8) |
| ≥80 | 151 | 25 (16.5) | 14 (9.3) | 11 (7.3) |
| Total | 1725 | 128 (7.4) | 89 (5.2) | 39 (2.3) |
| Age group, y . | All individuals . | All MBL (%) . | CLL-like MBL (%) . | Non–CLL-like MBL (%)* . |
|---|---|---|---|---|
| <40 | 403 | 7 (1.7) | 1 (0.2) | 6 (1.5) |
| 40-49 | 235 | 6 (2.5) | 4 (1.7) | 2 (0.9) |
| 50-59 | 317 | 19 (6.0) | 15 (4.7) | 4 (1.3) |
| 60-69 | 355 | 37 (10.4) | 31 (8.7) | 6 (1.7) |
| 70-79 | 264 | 34 (12.9) | 24 (9.1) | 10 (3.8) |
| ≥80 | 151 | 25 (16.5) | 14 (9.3) | 11 (7.3) |
| Total | 1725 | 128 (7.4) | 89 (5.2) | 39 (2.3) |
Includes CD5– and atypical CLL-MBL.